Xenetic Biosciences (NASDAQ:XBIO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Xenetic Biosciences (XBIO) operate in?

Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Xenetic Biosciences Stock (NASDAQ: XBIO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	18.00 / 20.51K
Day Range	- - -
52 Wk Range	2.78 - 5.20
Market Cap	$6.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	1.02%
Days to Cover	1.29

Recent News

Xenetic Biosciences Reports Q1 Loss, Misses Revenue Estimates

Xenetic Biosciences (NASDAQ: XBIO) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.60 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences

Vandana Singh

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	18.00 / 20.51K
Day Range	- - -
52 Wk Range	2.78 - 5.20
Market Cap	$6.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	1.02%
Days to Cover	1.29

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Xenetic Biosciences (XBIO) stock?

You can purchase shares of Xenetic Biosciences (NASDAQ:XBIO) through any online brokerage.

View our list of the best stock brokerages

Who are Xenetic Biosciences (XBIO) competitors?

Other companies in Xenetic Biosciences’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Coeptis Therapeutics (NASDAQ:COEP) and ABVC BioPharma (NASDAQ:ABVC).

What is the forecast, or price target, for Xenetic Biosciences (XBIO) stock?

There is no analysis for Xenetic Biosciences to provide a consensus price target.

What is the current price for Xenetic Biosciences (XBIO)?

The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $4.16 last updated November 21, 2024 at 8:31 AM EST.

Does Xenetic Biosciences (XBIO) pay a dividend?

There are no upcoming dividends for Xenetic Biosciences.

When is Xenetic Biosciences (NASDAQ:XBIO) reporting earnings?

Xenetic Biosciences’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Xenetic Biosciences (XBIO) going to split?

There is no upcoming split for Xenetic Biosciences.

What sector and industry does Xenetic Biosciences (XBIO) operate in?

Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Xenetic Biosciences

Xenetic Biosciences (XBIO) Forecast